bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2013: M A M F J
2012: D N O S A J J M

 
  Other news for:
Neoplasms
Ovarian Neoplasms
Labor
Physicians
Vaginal Smears
Pregnancy
 Resources from HONselect
Ob-Gyn Group Lists Procedures That May Not Be Needed
As part of the 'Choosing Wisely' campaign, ACOG asks docs, patients to question certain practices

By Robert Preidt

SUNDAY, March 3 (HealthDay News) -- Five tests and procedures that obstetricians/gynecologists and their patients should question the need for are outlined in a list released by the American College of Obstetricians and Gynecologists (ACOG) as part of the Choosing Wisely campaign.

The American Board of Internal Medicine Foundation-led campaign involves about 35 medical specialty groups and is intended to encourage patients and doctors to discuss appropriate care while avoiding unnecessary tests and treatments. ACOG is one of 17 medical societies that recently released advice lists.

"We carefully selected the five procedures and tests in ob-gyn based on their potential to improve quality health care and avoid potential harm. As ob-gyns, our goal is to provide women the very best evidence-based medical care," Dr. Hal Lawrence III, ACOG executive vice president, said in a college news release.

Here are the ACOG recommendations:

  • Elective, non-medically indicated inductions of labor or cesarean deliveries should not be scheduled before 39 weeks' gestation. Delivery prior to 39 weeks has been shown to be associated with an increased risk of learning disabilities and a potential increase in illness and death.
  • Elective, non-medically indicated inductions of labor between 39 weeks' and 41 weeks' gestation should not be scheduled unless the cervix is deemed favorable.
  • Routine annual Pap tests are not needed in women aged 30 to 65. In average-risk women, an annual screening offers no advantages over screening every three years.
  • Treatment is not needed in average-risk women who have "mild dysplasia," which is associated with the human papillomavirus (HPV), for a period of less than two years.
  • For average-risk women with no symptoms, there is no need to screen for ovarian cancer. In these women, the potential harms of screening outweigh the potential benefits.

More information

Here's where you can learn more about the Choosing Wisely campaign.

SOURCE: American College of Obstetricians and Gynecologists, news release, Feb. 21, 2013

Health News Copyright © 2013 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=673779

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Methods
Women
Neoplasms
Mass Screening
Ovarian Neoplasms
Therapeutics
Learning
Cervix Uteri
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact